Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company MannKind Corp.
DescriptionEndoplasmic reticulum to nucleus signaling 1 (ERN1; IRE1) alpha inhibitor
Molecular Target Endoplasmic reticulum to nucleus signaling 1 (ERN1) (IRE1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple myeloma (MM)
Indication DetailsTreat multiple myeloma (MM)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today